Panacos Pharmaceuticals (PANC)

[FORDGT]

Thanks, The Company's lead product candidate, bevirimat, is an oral HIV drug candidate in Phase II clinical testing. Panacos has dosed over 485 patients and subjects with bevirimat and have seen a good safety and tolerability profile with no indication of a relationship between adverse events and drug levels. The Company has exclusive rights from University of North Carolina at Chapel Hill (UNC) to the United States patent claiming the chemical entity bevirimat. Panacos has an exclusive worldwide license with UNC for all indications.
Bevirimat, also known as PA-457 or YK-FH312, is investigated in clinical trials for treating HIV infection. Bevirimat is a solid. ... It is not currently FDA-approved, but is undergoing clinical trials conducted by the pharmaceutical company Panacos ( PANC )

[Golden Cross]

$PANC Tier Change
Grey Market to Expert Market

[FORDGT]

Dark or Defunct
Caveat Emptor
Unable to Contact
Company is not able to provide disclosure to the public markets.
Dark or Defunct
Caveat Emptor
Unable to Contact

[FORDGT]

Volume(Heavy Day)
35,000
January 27, 2020 3:22pm

Panacos Pharmaceuticals, Inc. (Panacos) is a development-stage biotechnology company that seeks to develop next generation anti-infective products through the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases. The Company's lead product candidate, bevirimat, is an oral HIV drug candidate in Phase II clinical testing. Panacos has dosed over 485 patients and subjects with bevirimat and have seen a good safety and tolerability profile with no indication of a relationship between adverse events and drug levels. The Company has exclusive rights from University of North Carolina at Chapel Hill (UNC) to the United States patent claiming the chemical entity bevirimat. Panacos has an exclusive worldwide license with UNC for all indications.

[FORDGT]

Price $0.001 Day's Change 0.001 (99,900.00%)

[FORDGT]

Volume: 6,125 @07/05/19 3:39:17 PM EDT

[JohnnyBlaze]

lol 0.0001 - 0.005

[FORDGT]

[bPanacos Pharmaceuticals, Inc. (Panacos) is a development-stage biotechnology company that seeks to develop next generation anti-infective products through the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases. The Company's lead product candidate, bevirimat, is an oral HIV drug candidate in Phase II clinical testing. Panacos has dosed over 485 patients and subjects with bevirimat and have seen a good safety and tolerability profile with no indication of a relationship between adverse events and drug levels. The Company has exclusive rights from University of North Carolina at Chapel Hill (UNC) to the United States patent claiming the chemical entity bevirimat. Panacos has an exclusive worldwide license with UNC for all indications.

[FORDGT]

.0013 this looks good to me... To late to buy it now just watch this one Panacos Pharmaceuticals Inc PANC:Grey Market (Common Stock)

[FORDGT]

breakout on the way http://www.barchart.com/opinions/stocks/PANC

[FORDGT]

Could Have Ebola Here This story will bring PANC back from the dead..

[FORDGT]

Up 11% today with no bid and no ask... Get ready something is going to happen...

[FORDGT]

Good Post..

[sidedraft]

PANC: Suspended by SEC

http://www.sec.gov/litigation/suspensions/2014/34-71465.pdf

Order:

http://www.sec.gov/litigation/suspensions/2014/34-71465-o.pdf

[FORDGT]

% Above Low (08/08/13 - 01/02/13)

1,036.36% A very nice move year to date.. They have taken out the bottom.. This is ready for the move up.. With the talk of world pandemic we should see another 1000% move in this one... Best of Luck,,

[FORDGT]

http://www.profitspi.com/stock-chart.aspx?id=PANC&ca=566914257

[FORDGT]

VERY NICE!!! SOON COMING CHINA EFFECT... LOAD UP... I MAY BE THE ONLY HOLDER IN THE WORLD.... WANT TO SHOOT AT THE MOON BUY WHAT YOU CAN AFFORD TO LOSE... Panacos Pharmaceuticals, Inc. (Panacos) is a development-stage biotechnology company that seeks to develop next generation anti-infective products through the discovery and development of small-molecule oral drugs designed to treat human immunodeficiency virus (HIV) and other human viral diseases. The Company's lead product candidate, bevirimat, is an oral HIV drug candidate in Phase II clinical testing. Panacos has dosed over 485 patients and subjects with bevirimat and have seen a good safety and tolerability profile with no indication of a relationship between adverse events and drug levels. The Company has exclusive rights from University of North Carolina at Chapel Hill (UNC) to the United States patent claiming the chemical entity bevirimat. Panacos has an exclusive worldwide license with UNC for all indications.

[FORDGT]

Balance Sheet
Total Cash (mrq): 26.89M
Total Cash Per Share (mrq): 0.50
Total Debt (mrq): 18.21M
Total Debt/Equity (mrq): 345.33
Current Ratio (mrq): 2.15
Book Value Per Share (mrq): 0.10

[FORDGT]

SOME ONE STILL LIKES IT! Other than myself....

[FORDGT]

Key Executive

Pay

Dr. Alan W. Dunton M.D., 57
Chief Exec. Officer, Pres and Director

637.00K

[FORDGT]

Panacos trading again 240,000 ....

[BIG FACE HUNDREDS]

anybody know what the current float is on PANC?

[-Ed]

I got time, they will vind PANC when it rock.

[OCKHAM'S RAZOR]

PANC HOD was .0185

[OCKHAM'S RAZOR]

Heavy bids.... PANC looks interesting ..

[-Ed]

200 Pieces and back to 0,01 pffff
Who is selling this S..T

[FORDGT]

The news is 3 we have had 3 candle sticks in a row... And 5 cent is not to far away... Looking very good... Or maybe it's ONE because this stock is now in the 1 % percent of all advancing stocks... check the link http://www.barchart.com/snapopinion/stocks/PANC

[-Ed]

low volume but whe got 0,016 now

[OCKHAM'S RAZOR]

Seems like she is going higher.

[OCKHAM'S RAZOR]

PANC : buyout rumor is unfounded..imo

[OCKHAM'S RAZOR]

Wachout for PANC breakout at .018 - .09

could see .025 real quick and then some.

Target could be .04- .06.



volume heavier...would like to see news

[-Ed]

The volume is growing day by day, have the 0,017 see on the boards

[-Ed]

0,015 on the boards, the train is starting

[-Ed]

Cant find real news but there is something good news comming.

[FORDGT]

That chart does look good... 5 cents looks possible this month..

[OCKHAM'S RAZOR]

Accumulation has been very bullish.

[OCKHAM'S RAZOR]

WEEKLY CHART - PANC

[OCKHAM'S RAZOR]

You were lucky...was a gift..enjoy it while this moves..you must someoen on your side

; )

[-Ed]

Wow i bought on 0,001 for $ 3000,- and today 0,013 on the boards :)

[OCKHAM'S RAZOR]

She looks like she wants to go higher for some reason

Would like to hear from the company

[OCKHAM'S RAZOR]

PANC - I know that...bought some today.

Is there a specific reason you like them? BIG PHARMA BUYOUT,etc?
Looks good with increasing volume.>Would like to add closer to .01

[-Ed]

Pharma's are money makers, i got them on 0,001 :) a lot

[OCKHAM'S RAZOR]

WHY DO YOU LIKE PANC?

[-Ed]

Dunno but i'll wait, the day comes for rocket time

[OCKHAM'S RAZOR]

PANC looking interesting here

YOu still bullish on it?

[-Ed]

last news for panc :)insert-text-here

[-Ed]

Hope they get higher, thz for the post.

-Ed

[FORDGT]

STEADY CLIMB !! http://www.profitspi.com/stock-chart.aspx?id=PANC&ca=1554458243

[-Ed]

0,018 its alive

[FORDGT]

Chart looking good...